[Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced / Q000401:mortality; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D019934:International Normalized Ratio; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D012307:Risk Factors; D016019:Survival Analysis; D013923:Thromboembolism / Q000097:blood / Q000188:drug therapy*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; C403769:certoparin